Prediction of Postpartum Depression: Take a Closer Look at Question 3 on the PHQ-9
A routinely administered single-item measure of sleep disturbance could identify pregnant individuals who are at risk for PPD and may benefit from depression prevention efforts.
Using Metabolic Biomarkers to Predict Risk for Postpartum Depression
Metabolic biomarkers in the cerebrospinal fluid may be used to identify women at high risk for postpartum depression.
New Oral PPD Treatment Zuranolone Will Soon Hit the Market as Zurzuvae
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
We are looking to include two additional women who are early on in the postpartum period and recovering from postpartum depression (PPD).
Interested in participating in future research at the CWMH? You are invited to complete our interest form.
PMS & PMDD
When PMS symptoms interfere with functioning and quality of life
Fertility & Mental Health
Stress, depression, and anxiety associated with infertility and its treatment
Perinatal Substance Use
How can we best address substance use in women of reproductive age?
Menopausal Symptoms
Depression, hot flashes, sleep disturbance… What are safe treatment for symptomatic midlife women?
Psychiatric Disorders During Pregnancy
Weighing the risks and benefits of pharmacologic treatment during pregnancy
Breastfeeding & Psychiatric Medications
How safe is it for women to take medications and breastfeed?
Postpartum Psychiatric Disorders
Most women suffering from postpartum depression do not receive adequate care
